Please login to the form below

Tcelna

This page shows the latest Tcelna news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA drops Ono-partnered multiple sclerosis drug

It also has a licensing deal in place for Tcelna (imilecleucel-T), a personalised treatment for secondary-progressive MS developed by Opexa Therapeutics that is in phase IIb testing with

Latest news

Currencies hit Merck Serono sales but firm says it is 'on course'

Overall groups sales down to €2.84bn for second quarter of 2013
Merck KGaA to meet 2014 financial targets one year early

and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.
Merck KGaA and Opexa enter MS deal

Will develop personalised T-cell based medicine Tcelna. Merck KGaA has agreed a deal with Opexa Therapeutics to develop and commercialise a new personalised treatment for multiple sclerosis (MS). ... During the SPMS trial, patients undergo two annual

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2013

sales. In the other option deal, Merck Serono has acquired an option over Opexa Therapeutics' phase IIb Tcelna (imilecleucel-T) vaccine for MS (for all territories except Japan). ... Tcelna is being developed as a personalised therapy specifically

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Director – Healthcare Marketing – Berks: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Account Director: Competative

Account Director: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Director development role to Business Director, H...: Excellent package

Associate Director: £75, 000-90, 000

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Business Director: Competitive Salary Offered

Senior Medical Writer: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director – Health Policy – Global Agency: Salary TBC

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...